VEGAPLAX
LIVE

Serial Number

79338708

Owner

ACMEDI KOREA Co., Ltd.

Attorney

Charles G. Zug

Filing Date

Mar 3, 2022

Add to watchlist:

No watchlists yet
View on USPTO

VEGAPLAX Trademark

Serial Number: 79338708 • Registration: 7123436

VEGAPLAX is a trademark filed by ACMEDI KOREA Co., Ltd. on March 3, 2022. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

ACMEDI KOREA Co., Ltd. (3 trademarks)

#611,612-1, 293, Mokdongdong-ro,

Entity Type: 03

Trademark Details

Filing Date

March 3, 2022

Registration Date

August 1, 2023

Published for Opposition

May 16, 2023

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 27, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 3, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 3, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 1, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 1, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 1, 2023 R.PR
NOTIFICATION PROCESSED BY IB
May 17, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 26, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 26, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 4, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 15, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 22, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 21, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 25, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 24, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 26, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 21, 2022 REPR